Cyclo Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Cyclo Therapeutics

10/03/2023 14:36

* Cyclo Therapeutics Inc  CYTH.OQ   CYTH.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 13
(estimated). 
    * The Gainesville Florida Florida-based  company is expected
to
report  a 9.6% increase in revenue to $642 thousand from $586
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cyclo Therapeutics
Inc is
for a loss of 25 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cyclo
Therapeutics Inc is $5​, above​ its last closing price of $1.06.
​​​

This summary was machine generated March 10 at 14:36 GMT.  All
figures in US dollars  unless otherwise stated